Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

✍ Scribed by Jian-Jun Li; Zong-Liang Lu; Wen-Rong Kou; Roberto Bolli; Zuo Chen; Yang-Feng Wu; Xue-Hai Yu; Yu-Cheng Zhao

• Book ID: 116550828
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 182 KB
• Volume: 154
• Category: Article
• ISSN: 0167-5273
• DOI: 10.1016/j.ijcard.2011.11.005